Section of Tissue Engineering and Stem Cell Therapy, Pediatric Urology and Regenerative Medicine Research Center, Children's Hospital Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, No. 62, Dr.Gharib's Street, Keshavarz Boulevard, Tehran, 1419733151, Iran.
Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Pediatr Nephrol. 2021 Mar;36(3):631-638. doi: 10.1007/s00467-020-04750-w. Epub 2020 Sep 16.
To evaluate and compare the efficacy of urinary carbohydrate antigen 19-9 (CA19-9), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) biomarkers as predictive factors to determine the surgery requirement in patients with ureteropelvic junction obstruction.
We obtained urine samples from 161 patients at diagnosis and evaluated their levels of the three biomarkers. The patients were under observation for 2 years; subsequently, they were divided into two groups based on their requirement of pyeloplasty. We determined the correlation between the urinary concentration of the biomarkers and surgical interventions, as well as the kidney function deterioration and sonography outcomes.
The non-surgery group included 60 male and 22 female patients with mean age of 21 months. The surgery group comprised 58 boys and 21 girls with mean age of 26.9 months with no significant difference of age and gender between the two groups. The outcomes were indicative of higher efficacy of CA19-9 level with a sensitivity and specificity of 84.2% and 73.2% at the cutoff point of 59.09 U/ml. Also, a significant negative correlation was detected between the kidney function and the concentrations of CA19-9 and NGAL.
Our evaluations demonstrate the higher efficacy of CA19-9 to predict the requirement of surgical intervention in comparison with the other biomarkers, as well as a significant correlation between kidney function deterioration and urinary CA19-9 and NGAL. The outcomes of this investigation could pave the way for more extensive clinical application of these urinary biomarkers, besides future research determining the association between markers and kidney fibrosis.
评估和比较尿碳水化合物抗原 19-9(CA19-9)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和肾损伤分子-1(KIM-1)生物标志物作为预测因素,以确定肾盂输尿管连接部梗阻患者的手术需求。
我们在诊断时从 161 名患者中获得尿液样本,并评估了这三种生物标志物的水平。这些患者被观察了 2 年;随后,根据他们对肾盂成形术的需求,将他们分为两组。我们确定了生物标志物的尿液浓度与手术干预之间的相关性,以及肾功能恶化和超声结果之间的相关性。
非手术组包括 60 名男性和 22 名女性,平均年龄为 21 个月。手术组包括 58 名男孩和 21 名女孩,平均年龄为 26.9 个月,两组在年龄和性别上无显著差异。结果表明,CA19-9 水平的疗效更高,其截断值为 59.09 U/ml 时,敏感性和特异性分别为 84.2%和 73.2%。此外,肾功能与 CA19-9 和 NGAL 浓度之间存在显著负相关。
我们的评估表明,CA19-9 在预测手术干预需求方面的效果优于其他生物标志物,而且肾功能恶化与尿液 CA19-9 和 NGAL 之间存在显著相关性。本研究的结果为这些尿生物标志物的更广泛临床应用铺平了道路,同时也为未来确定标志物与肾脏纤维化之间的关系的研究提供了参考。